VALENCIA HAYES: Open Payments
NPI 1932577111 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,120 in 188 payments from 40 companies in 2025. Trend: 2023 $5,950 · 2024 $4,456 · 2025 $4,120
Food & beverage: $4,120
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 14 | $370 |
| Merck Sharp & Dohme LLC | 13 | $308 |
| Incyte Corporation | 9 | $307 |
| PFIZER INC. | 15 | $303 |
| AstraZeneca Pharmaceuticals LP | 13 | $291 |
| Janssen Biotech, Inc. | 15 | $253 |
| Novartis Pharmaceuticals Corporation | 10 | $185 |
| E.R. Squibb & Sons, L.L.C. | 9 | $181 |
| GlaxoSmithKline, LLC. | 7 | $167 |
| BeOne Medicines USA, Inc. | 8 | $141 |
Products named: JAKAFI, REBLOZYL, KEYTRUDA, OPDIVO, BRUKINSA, IMFINZI, ENHERTU, OPDUALAG.
Industry payments across FL — which companies pay providers there.
